In addition to probably mild malnutrition (albumin 3.3 g/dL; normal range, 3.5 to 5.0 g/dL), the patient had no identifiable risk factors, except for having received acetazolamide. The patient had ...

A recent study (NORDIC Study Group et al., 2014) examined the treatment of IIH with acetazolamide, a carbonic anhydrase inhibitor that is thought to reduce intracranial pressure in part by ...